SEC Filings

SC 13G/A
MEDTRONIC PLC filed this Form SC 13G/A on 09/15/2017
Entire Document

Item 1(a) Name of Issuer:

Mazor Robotics Ltd.


Item 1(b) Address of Issuer’s Principal Executive Offices:

PO Box 3104

5 Shacham St.

Caesarea North Industrial Park

3088900, Israel


Item 2(a) Name of Persons Filing:

Medtronic plc

Covidien Group S.a.r.l.

Medtronic plc (“Medtronic”) and its wholly-owned subsidiary, Covidien Group S.a.r.l. (“Covidien”), are jointly filing this Amendment No. 1 (this “Amendment”) to the Statement of Beneficial Ownership on Schedule 13G filed on August 22, 2016 (the “Statement”) to report their acquisition, on September 12, 2017, of (i) an additional 1,040,106 American Depositary Shares (“ADSs”), which represent 2,080,212 ordinary shares, and (ii) warrants (“Warrants”) to purchase an additional 1,210,000 ADSs, or 2,420,000 ordinary shares, which together with their preexisting holdings, have increased their holdings above 10% of the outstanding ordinary shares of the Issuer. Covidien holds all of such ADSs and Warrants directly, while Medtronic may be deemed to share beneficial ownership over all of such ADSs and Warrants by virtue of its control of Covidien.


Item 2(b) Address of Principal Business Office or, if None, Residence:

Medtronic: 20 Lower Hatch Street, Dublin 2, Ireland

Covidien: 3b, Bd. Prince Henri, 4th Floor L-1724 Luxembourg


Item 2(c) Citizenship:

Medtronic: Ireland

Covidien: Luxembourg


Item 2(d) Title of Class of Securities:

American Depository Shares, represented by American Depository Receipts, each representing two Ordinary Shares, par value NIS 0.01 per share


Item 2(e) CUSIP Number:



Item 3 If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:


  (a) ☐ Broker or dealer registered under Section 15 of the Act.


  (b) ☐ Bank as defined in Section 3(a)(6) of the Act.


  (c) ☐ Insurance company as defined in Section 3(a)(19) of the Act.


Page 4 of 7